Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice

Acinetobacter baumannii poses a serious threat to human health, mainly because of its widespread distribution and severe drug resistance. However, no licensed vaccines exist for this pathogen. In this study, we created a conjugate vaccine against A. baumannii by introducing an O‐linked glycosylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Pan, Chao, Liu, Zhicheng, Sun, Peng, Hua, Xiaoting, Feng, Erling, Yu, Yunsong, Wu, Jun, Zhu, Li, Wang, Hengliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867989/
https://www.ncbi.nlm.nih.gov/pubmed/33755314
http://dx.doi.org/10.1111/1751-7915.13770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867989/
https://www.ncbi.nlm.nih.gov/pubmed/33755314
http://dx.doi.org/10.1111/1751-7915.13770

Ejemplares similares